Apella Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Apella Capital's MRK Position: Q2 2026 in Review
Apella Capital increased its Merck (MRK) stake by 1.4% in Q2 2026, buying an estimated $61.6K and bringing the position to 37,663 shares worth $4.85M. The position accounts for 0.07% of the portfolio, ranked #167.
Apella Capital first reported a position in MRK in Q1 2020 and has held it in 25 quarters since. 1,811 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Apella Capital held 37,663 shares of Merck worth $4.85M as of Q2 2026.
- Apella Capital bought 526 Merck shares in Q2 2026, an estimated $61.6K.
- Merck made up 0.07% of Apella Capital's portfolio in Q2 2026, its #167 holding.
- Apella Capital first reported a position in Merck in Q1 2020 and has held it in 25 quarters since.
- 1,811 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.